EGFR and cancer: It has also been shown that lactate (produced by MET/EGFR TKI-resistant cancer cells) enhances the production/secretion of HGF by cancer-associated fibroblasts, which in turn activates MET-dependent signalling pathways in cancer cells, causing adaptive resistance to MET inhibitors [89].